Outpatient Treatment of Infective Endocarditis at Physician Office Infusion Centers (POICs): A 2-Year Analysis of Clinical and Economic Outcomes

Presented on October 24, 2016

Brian S. Metzger, MD, MPH
Richard M. Mandel, MD, FIDSA
Jorge R. Bernett, MD
Barry Statner, MD, FRCPC, FIDSA
John S. Adams, MD, FIDSA, FSHEA
Alfred E. Bacon, III, MD
Kimberly Couch, PharmD, MA, FIDSA, FASHP
Claudia P. Schroeder, PharmD, PhD
Lucinda J. Van Anglen, PharmD

View Abstract

View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in therapies for COVID-19, Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.